3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Hodgkin Disease
13
Lymphoma, Non-Hodgkin
11
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Leukemia, Biphenotypic, Acute
8
Leukemia
8
Burkitt Lymphoma
7
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, Mantle-Cell
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Rhabdomyosarcoma
4
Multiple Myeloma
4
Lymphoma, Follicular
4
Anemia, Refractory, with Excess of Blasts
4
Medulloblastoma
3
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Magnetic Resonance Spectroscopy
7
lutetium Lu 177 dotatate
6
Specimen Handling
5
Bevacizumab
4
gallium Ga 68 dotatate
3
abemaciclib
3
Radiosurgery
3
Proton Therapy
3
Nivolumab
3
pembrolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Protons
2
Observation
2
ONC206
2
Ipilimumab
2
Hydroxyurea
2
Ga(III)-DOTATOC
2
Everolimus
2
Elasticity Imaging Techniques
2
CTLA-4 Antigen
2
ribociclib
1
regorafenib
1
olaparib
1
neratinib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
capivasertib
1
cabozantinib
1
brigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
Filgrastim
×
1 year
×
Clear all
No trials found.